• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations.肥胖与非酒精性脂肪性肝病:亚洲人群中的不同关联。
World J Hepatol. 2014 May 27;6(5):263-73. doi: 10.4254/wjh.v6.i5.263.
2
Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.分子机制:非酒精性脂肪性肝病、脂肪性肝炎和肝细胞癌之间的联系。
Int J Mol Sci. 2020 Feb 23;21(4):1525. doi: 10.3390/ijms21041525.
3
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.建立中国、法国、德国、意大利、日本、西班牙、英国和美国 2016-2030 年非酒精性脂肪性肝病疾病负担模型。
J Hepatol. 2018 Oct;69(4):896-904. doi: 10.1016/j.jhep.2018.05.036. Epub 2018 Jun 8.
4
[Future of pharmacological treatment of non-alcoholic steatohepatitis in terms of key pathophysiological mechanisms].[从关键病理生理机制角度看非酒精性脂肪性肝炎的药物治疗前景]
Vnitr Lek. 2018 Fall;64(7-8):735-741.
5
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的临床流行病学和疾病负担。
World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263.
6
Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study.肥胖指数、代谢健康和脂肪组织炎症对减重手术患者非酒精性脂肪性肝病严重程度的影响:一项前瞻性研究。
Obes Surg. 2019 Jan;29(1):99-108. doi: 10.1007/s11695-018-3479-2.
7
Nonalcoholic Steatohepatitis: A Review.非酒精性脂肪性肝炎:综述。
JAMA. 2020 Mar 24;323(12):1175-1183. doi: 10.1001/jama.2020.2298.
8
Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.肝移植术后非酒精性脂肪性肝炎肝硬化的转归:与酒精性肝硬化的比较。
Ann Hepatol. 2019 Nov-Dec;18(6):855-861. doi: 10.1016/j.aohep.2019.06.014. Epub 2019 Sep 6.
9
Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.非酒精性脂肪性肝病伴低内脏性肥胖患者的非酒精性脂肪性肝炎和纤维化风险。
J Hepatol. 2011 Jun;54(6):1244-9. doi: 10.1016/j.jhep.2010.09.037. Epub 2010 Nov 11.
10
Liver transplantation and non-alcoholic fatty liver disease.肝移植与非酒精性脂肪性肝病
World J Gastroenterol. 2014 Nov 14;20(42):15532-8. doi: 10.3748/wjg.v20.i42.15532.

引用本文的文献

1
Impact of Pathological Grades of Metabolic Dysfunction-Associated Steatotic Liver Disease on Weight Loss Following Laparoscopic Sleeve Gastrectomy.代谢功能障碍相关脂肪性肝病的病理分级对腹腔镜袖状胃切除术后体重减轻的影响
Diabetes Metab Syndr Obes. 2025 Jul 29;18:2547-2560. doi: 10.2147/DMSO.S523771. eCollection 2025.
2
Hepatoprotective and Antiatherosclerotic Effects of Oleoylethanolamide-Based Dietary Supplement in Dietary-Induced Obesity in Mice.基于油酰乙醇胺的膳食补充剂对饮食诱导的小鼠肥胖的肝脏保护和抗动脉粥样硬化作用
Pathophysiology. 2025 Apr 18;32(2):16. doi: 10.3390/pathophysiology32020016.
3
Prevalence of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Persons with Obesity and Type 2 Diabetes Mellitus: A Cross-sectional Study.肥胖和2型糖尿病患者中代谢功能障碍相关脂肪性肝病(MASLD)的患病率:一项横断面研究。
Euroasian J Hepatogastroenterol. 2024 Jul-Dec;14(2):129-133. doi: 10.5005/jp-journals-10018-1437. Epub 2024 Dec 27.
4
Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence, Diagnosis, Treatment, and Outcomes: A Narrative Review.代谢功能障碍相关脂肪性肝病在患病率、诊断、治疗及预后方面的差异:一项叙述性综述
Dig Dis Sci. 2025 Jan;70(1):154-167. doi: 10.1007/s10620-024-08722-0. Epub 2024 Nov 19.
5
Protecting our future: environmental hazards and children's health in the face of environmental threats: a comprehensive overview.保护我们的未来:面对环境威胁时的环境危害与儿童健康:全面概述
Clin Exp Pediatr. 2024 Nov;67(11):589-598. doi: 10.3345/cep.2023.01578. Epub 2024 Oct 31.
6
Exploring shared molecular signatures and regulatory mechanisms in nonalcoholic steatohepatitis and inflammatory bowel disease using integrative bioinformatics analysis.运用综合生物信息学分析方法探究非酒精性脂肪性肝炎和炎症性肠病的共有分子特征和调控机制。
Sci Rep. 2024 May 27;14(1):12085. doi: 10.1038/s41598-024-62310-w.
7
Non-invasive biomarkers prognostic of decompensation events in NASH cirrhosis: a systematic literature review.非侵入性生物标志物预测 NASH 肝硬化失代偿事件:系统文献回顾。
J Mol Med (Berl). 2024 Jul;102(7):841-858. doi: 10.1007/s00109-024-02448-2. Epub 2024 May 16.
8
Effect of Green and Red Thai Kratom (Mitragyna speciosa) on pancreatic digestive enzymes (alpha-glucosidase and lipase) and acetyl-carboxylase 1 activity: A possible therapeutic target for obesity prevention.泰国绿红东革阿里(Mitragyna speciosa)对胰腺消化酶(α-葡萄糖苷酶和脂肪酶)和乙酰辅酶 A 羧化酶 1 活性的影响:肥胖预防的潜在治疗靶点。
PLoS One. 2023 Sep 21;18(9):e0291738. doi: 10.1371/journal.pone.0291738. eCollection 2023.
9
Natural products targeting inflammation-related metabolic disorders: A comprehensive review.针对炎症相关代谢紊乱的天然产物:综述
Heliyon. 2023 Jun 2;9(6):e16919. doi: 10.1016/j.heliyon.2023.e16919. eCollection 2023 Jun.
10
Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies.非酒精性脂肪性肝病/非酒精性脂肪性肝炎相关肝细胞癌(HCC)切除术:与其他病因引起的 HCC 的临床特征和结局比较。
Oncologist. 2023 Apr 6;28(4):341-350. doi: 10.1093/oncolo/oyac251.

本文引用的文献

1
Reducing racial/ethnic disparities in childhood obesity: the role of early life risk factors.减少儿童肥胖中的种族/民族差异:早期生活风险因素的作用。
JAMA Pediatr. 2013 Aug 1;167(8):731-8. doi: 10.1001/jamapediatrics.2013.85.
2
Black-white disparities in overweight and obesity trends by educational attainment in the United States, 1997-2008.1997 - 2008年美国按教育程度划分的超重和肥胖趋势方面的黑白差异。
J Obes. 2013;2013:140743. doi: 10.1155/2013/140743. Epub 2013 Apr 10.
3
Increasing trends in central obesity among Chinese adults with normal body mass index, 1993-2009.中国成年人正常体重指数中心性肥胖趋势增加,1993-2009 年。
BMC Public Health. 2013 Apr 10;13:327. doi: 10.1186/1471-2458-13-327.
4
NAFLD in Asia--as common and important as in the West.亚洲的非酒精性脂肪性肝病——与西方一样普遍且重要。
Nat Rev Gastroenterol Hepatol. 2013 May;10(5):307-18. doi: 10.1038/nrgastro.2013.34. Epub 2013 Mar 5.
5
Racial and ethnic residential segregation, the neighborhood socioeconomic environment, and obesity among Blacks and Mexican Americans.黑人和墨西哥裔美国人的种族和民族居住隔离、邻里社会经济环境与肥胖。
Am J Epidemiol. 2013 Feb 15;177(4):299-309. doi: 10.1093/aje/kws372. Epub 2013 Jan 20.
6
Prevalence of obesity among young Asian-American children.亚裔美国儿童肥胖症的流行情况。
Child Obes. 2012 Dec;8(6):518-25. doi: 10.1089/chi.2011.0077.
7
Racial disparities in the risk of developing obesity-related diseases: a cross-sectional study.种族差异与肥胖相关疾病风险:一项横断面研究。
Ethn Dis. 2012 Summer;22(3):308-16.
8
More than a quarter of a century of liver transplantation in Kaohsiung Chang Gung Memorial Hospital.高雄长庚纪念医院超过四分之一个世纪的肝脏移植历程。
Clin Transpl. 2011:213-21.
9
Etiologic types of end-stage chronic liver disease in adults: analysis of prevalence and their temporal changes from a study on native liver explants.成人终末期慢性肝病的病因类型:一项对原位肝移植标本的研究分析其患病率及其时间变化。
Eur J Gastroenterol Hepatol. 2012 Oct;24(10):1199-208. doi: 10.1097/MEG.0b013e32835643f1.
10
Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese.非肥胖亚洲人群中非酒精性脂肪性肝病的流行情况及危险因素。
J Gastroenterol Hepatol. 2012 Oct;27(10):1555-60. doi: 10.1111/j.1440-1746.2012.07222.x.

肥胖与非酒精性脂肪性肝病:亚洲人群中的不同关联。

Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations.

作者信息

Wong Robert J, Ahmed Aijaz

机构信息

Robert J Wong, Aijaz Ahmed, Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, United States.

出版信息

World J Hepatol. 2014 May 27;6(5):263-73. doi: 10.4254/wjh.v6.i5.263.

DOI:10.4254/wjh.v6.i5.263
PMID:24868320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4033284/
Abstract

Obesity is a global epidemic contributing to an increasing prevalence of obesity-related systemic disorders, including nonalcoholic fatty liver disease. The rising prevalence of nonalcoholic steatohepatitis (NASH) will in the near future lead to end-stage liver disease in a large cohort of patients with NASH-related cirrhosis and NASH is predicted to be a leading indication for liver transplantation in the coming decade. However, the prevalence of obesity and the progression of hepatic histological damage associated with NASH exhibit significant ethnic disparities. Despite a significantly lower body mass index and lower rates of obesity compared to other ethnic groups, Asians continue to demonstrate a significant prevalence of hypertension, diabetes, metabolic syndrome and NASH. Ethnic disparities in central adiposity and visceral fat distribution have been hypothesized to contribute to these ethnic disparities. The current review focuses on the epidemiology of obesity and NASH among Asian populations.

摘要

肥胖是一种全球性流行病,导致与肥胖相关的全身性疾病的患病率不断上升,包括非酒精性脂肪性肝病。非酒精性脂肪性肝炎(NASH)患病率的上升在不久的将来将导致大量NASH相关肝硬化患者发展为终末期肝病,预计在未来十年NASH将成为肝移植的主要指征。然而,肥胖的患病率以及与NASH相关的肝脏组织学损伤的进展存在显著的种族差异。尽管与其他种族相比,亚洲人的体重指数显著较低且肥胖率较低,但亚洲人高血压、糖尿病、代谢综合征和NASH的患病率仍然很高。中心性肥胖和内脏脂肪分布的种族差异被认为是导致这些种族差异的原因。本综述重点关注亚洲人群中肥胖和NASH的流行病学。